Effects of Ultrafine Bubble Water on Gut Microbiota Composition and Health Markers in Rats
Source abstract
Abstract
Ultrafine bubbles (UFBs) represent an emerging technology with unique physicochemical properties. This study investigated the effects of air-filled UFBs infused in drinking water on gut microbiota composition and the associated health markers in Sprague Dawley rats over a 12-week period. Using a two-phase design, UFB concentration was increased from 1.7 × 106 to 6.5 × 109 UFBs/mL at week 7 to assess dose-dependent effects. Administration of UFBs in drinking water induced significant shifts in gut microbiome populations, characterized by increased Bacteroidetes (+122% weeks 8–12) and decreased Firmicutes (−43% weeks 8–12) compared to controls. These microbial shifts coincided with enhanced short-chain fatty acid production (butyrate +56.0%, p ≤ 0.001; valerate +63.1%, p ≤ 0.01) and reduced inflammatory markers (TNF-α −84.0%, p ≤ 0.05; IL-1β −41.0%, p ≤ 0.05; IL-10 −69.8%, p ≤ 0.05). UFB effects demonstrated systematic concentration-dependent threshold responses, with 85.7% of parameters exhibiting directional reversals between low (1.7 × 106 UFBs/mL) and high (6.5 × 109 UFBs/mL) concentration phases rather than linear dose–response relationships. The systematic nature of these threshold effects, with 71.4% of parameters achieving statistical significance (p ≤ 0.05), indicates concentration-dependent biological mechanisms rather than random effects on gut biology. Despite current metagenomic techniques identifying only 25% of the total gut microbiome, the observed changes in characterized species and metabolites demonstrate UFB technology’s therapeutic potential for conditions requiring microbiome modulation, providing new insights into UFB influence on complex biological systems.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Hydrogen's biological and therapeutic effects · Thermoregulation and physiological responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hydrosome Labs LLC, 640 Blackhawk Drive, Westmont, IL 60559, USA
References (35)
Show source-provided references
1. Fundamentals and Applications of Nanobubbles: A Review10.1016/j.cherd.2022.11.013 ↗
2. Nanobubbles: An Emerging Science in Nanotechnology10.4103/mgmj.MGMJ_59_23 ↗
3. Mechanisms on Stability of Bulk Nanobubble and Relevant Applications: A review10.1016/j.jclepro.2023.139153 ↗
4. Generation and Stability of Bulk Nanobubbles: A Review and Perspective10.1016/j.cocis.2021.101439 ↗
5. Terasaka, K., Yasui, K., Kanematsu, W., and Aya, N. (2021). Ultrafine Bubbles, Jenny Standford Publishing.10.1201/9781003141952 ↗
6. (2017). Fine Bubble Technology—General Principles for Usage and Measurement of Fine Bubbles—Part 1: Terminology (Standard No. ISO-20480-1:2017).
7. Aqueous Dispersions of Nanobubbles: Generation, Properties and Features10.1016/j.mineng.2016.05.001 ↗
8. Novel Nanobubble Technology in Food Science: Application and Mechanism10.48130/FIA-2023-0014 ↗
9. Micro and Nanobubble Technologies as a New Horizon for Water-Treatment Techniques: A Review10.1016/j.cis.2017.06.011 ↗
10. Dynamic Equilibrium Mechanism for Surface Nanobubble Stabilization10.1103/PhysRevLett.101.214505 ↗
11. Unraveling the Mystery of Ultrafine Bubbles: Establishment of Thermodynamic Equilibrium for Sub-Micron Bubbles and Its Implications10.1016/j.jcis.2020.02.101 ↗
12. On the Existence and Stability of Bulk Nanobubbles10.1021/acs.langmuir.8b01163 ↗
13. Ito, M., and Sugai, Y. (2021). Nanobubbles Activate Anaerobic Growth and Metabolism of Pseudomonas aeruginosa. Sci. Rep., 11.10.1038/s41598-021-96503-4 ↗
14. Park, Y., Shin, S., Shukla, N., Kim, K., and Park, M.-H. (2022). Effects of Nanobubbles in Dermal Delivery of Drugs and Cosmetics. Nanomaterials, 12.10.3390/nano12193286 ↗
15. Supplementation of O2-Containing Gas Nanobubble Water to Enhance Methane Production from Anaerobic Digestion of Cellulose10.1016/j.cej.2020.125652 ↗
16. The Gut Microbiome in Health and in Disease10.1097/MOG.0000000000000139 ↗
17. The Gut Microbiome: Relationships with Disease and Opportunities for Therapy10.1084/jem.20180448 ↗
18. Supplementation with Nanobubble Water Alleviates Obesity-Associated Markers through Modulation of Gut Microbiota in High-Fat Diet Fed Mice10.1016/j.jff.2020.103820 ↗
19. Formation of Propionate and Butyrate by the Human Colonic Microbiota10.1111/1462-2920.13589 ↗
20. Transfer of Energy Substrates across the Ruminal Epithelium: Implications and Limitations10.1079/AHRR200237 ↗
21. Review Article: Short Chain Fatty Acids as Potential Therapeutic Agents in Human Gastrointestinal and Inflammatory Disorders10.1111/apt.14689 ↗
22. Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., and Furet, J.-P. (2009). The Firmicutes/Bacteroidetes Ratio of the Human Microbiota Changes with Age. BMC Microbiol., 9.10.1186/1471-2180-9-123 ↗
23. Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.10.3390/nu12051474 ↗
24. Association of Gut Microbiota and Inflammatory Markers in Obese Patients with Type 2 Diabetes Mellitus: Post Hoc Analysis of a Synbiotic Interventional Study10.12938/bmfh.2021-081 ↗
25. Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity10.1016/j.cell.2016.10.020 ↗
26. Parada Venegas, D., De La Fuente, M.K., Landskron, G., González, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol., 10.10.3389/fimmu.2019.01486 ↗
27. Wolfe, W., Xiang, Z., Yu, X., Li, P., Chen, H., Yao, M., Fei, Y., Huang, Y., Yin, Y., and Xiao, H. (2023). The Challenge of Applications of Probiotics in Gastrointestinal Diseases. Adv. Gut Microbiome Res., 2023.10.1155/2023/1984200 ↗
28. The Gut Microbiota, Bacterial Metabolites and Colorectal Cancer10.1038/nrmicro3344 ↗
29. Role of the Microbiota in Immunity and Inflammation10.1016/j.cell.2014.03.011 ↗
30. Probiotics and Prebiotics in Intestinal Health and Disease: From Biology to the Clinic10.1038/s41575-019-0173-3 ↗
31. Dong, L., Qin, C., Li, Y., Wu, Z., and Liu, L. (2022). Oat Phenolic Compounds Regulate Metabolic Syndrome in High Fat Diet-Fed Mice via Gut Microbiota. Food Biosci., 50.10.1016/j.fbio.2022.101946 ↗
32. Whole Grain Benefit: Synergistic Effect of Oat Phenolic Compounds and β-Glucan on Hyperlipidemia via Gut Microbiota in High-Fat-Diet Mice10.1039/D2FO01746F ↗
33. Metagenomic Insights into the Effects of Nanobubble Water on the Composition of Gut Microbiota in Mice10.1039/D0FO01592J ↗
34. Individuality in Gut Microbiota Composition Is a Complex Polygenic Trait Shaped by Multiple Environmental and Host Genetic Factors10.1073/pnas.1007028107 ↗
35. Consumption of the Fish Oil High-Fat Diet Uncouples Obesity and Mammary Tumor Growth through Induction of Reactive Oxygen Species in Protumor Macrophages10.1158/0008-5472.CAN-19-3184 ↗